Soma Sengupta, Chair and Neurologist-in-Chief at Tufts Medicine, shared a post on LinkedIn:
“As May approaches—I think about Glioblastoma Awareness Month:
I remember the warriors we have lost. Each memory is a tribute to who they were and the lives they touched.
I also think of those who continue to fight—patients and families navigating this journey with extraordinary courage.
Glioblastoma is relentless—not only in its biology, but in the toll it takes:
- The physical side effects of treatment, the cognitive and emotional impact.
- The very real financial toxicity that weighs on patients and families.
- At a time when research funding faces uncertainty, our commitment cannot waver.
- Progress depends on sustained investment, innovation, and advocacy—so we can not only extend survival, but improve quality of life.
I am continually in awe of this community—the resilience, the humanity, and the strength to keep going.
This May, I ask you to act:
- Learn and share information about glioblastoma
- Support research and clinical trials
- Advocate for sustained and equitable funding
- Recognize and address both treatment-related side effects and financial burden
- Stand with patients and families—your voice matters
Together, we can raise awareness, reduce suffering, and move closer to better treatments—and ultimately, a cure.”
More posts featuring Soma Sengupta.